On 8 may, IFPMA read the following statement at the Multi-stakeholder Hearing on Tuberculosis (TB) in New York.
Read moreDiscover how the innovative pharmaceutical industry works with partners to advance the SDGs
Read moreAhead of the Global Fund Seventh Replenishment for 2024-2026, the innovative biopharmaceutical industry reaffirms its longstanding commitment to support the Global Fund mission to defeat HIV, TB, and malaria, and ensure a healthier, safer, more equitable future for all.
Read more